Law-ref.org REACH - Registration, Evaluation and Authorisation of Chemicals
Site search

commerce [Global Index]


... 45. The European Inventory of Existing Commercial Chemical Substances (EINECS) included certain complex substances in a single entry. UVCB substances (substances of unknown or variable composition, complex reaction products or biological materials) may be registered as a single substance under this Regulation, despite their variable composition, provided that the hazardous properties do not differ significantly and warrant the same classification. ...


ARTICLE-3: Definitions     [go to this ARTICLE]
... (a) it is listed in the European Inventory of Existing Commercial Chemical Substances (EINECS); ...


ARTICLE-10: Information to be submitted for general registration purposes     [go to this ARTICLE]
... (xi) a request as to which of the information in Article 119(2) the manufacturer or importer considers should not be made available on the Internet in accordance with Article 77(2)(e), including a justification as to why publication could be harmful for his or any other concerned party's commercial interests. ...


ARTICLE-11: Joint submission of data by multiple registrants     [go to this ARTICLE]
... (b) submitting the information jointly would lead to disclosure of information which he considers to be commercially sensitive and is likely to cause him substantial commercial detriment; or ...
... If points (a), (b) or (c) apply, the registrant shall submit, along with the dossier, an explanation as to why the costs would be disproportionate, why disclosure of information was likely to lead to substantial commercial detriment or the nature of the disagreement, as the case may be. ...


ARTICLE-19: Joint submission of data on isolated intermediates by multiple registrants     [go to this ARTICLE]
... (b) submitting the information jointly would lead to disclosure of information which he considers to be commercially sensitive and is likely to cause him substantial commercial detriment; or ...
... If points (a), (b) or (c) apply, the manufacturer or importer shall submit, along with the dossier, an explanation as to why the costs would be disproportionate, why disclosure of information was likely to lead to substantial commercial detriment, or the nature of the disagreement, as the case may be. ...


ARTICLE-118: Access to information     [go to this ARTICLE]
... 2. Disclosure of the following information shall normally be deemed to undermine the protection of the commercial interests of the concerned person: ...


ARTICLE-119: Electronic public access     [go to this ARTICLE]
... 2. The following information on substances whether on their own, in preparations or in articles, shall be made publicly available, free of charge, over the Internet in accordance with Article 77(2)(e) except where a party submitting the information submits a justification in accordance with Article 10(a)(xi), accepted as valid by the Agency, as to why such publication is potentially harmful for the commercial interests of the registrant or any other party concerned: ...